N.H. Code Admin. R. Ph 704.02
Prospective Drug Review
Effective Jun 22, 2022#5552 INTERIM eff 1-8-93, EXPIRES 5-8-93; ss by #5622, eff 5-8-93; ss by #6181-B, eff 2-5-96, EXPIRED: 2-5-04 New. #8316, eff 3-26-05, EXPIRED: 3-26-13 New. #10903, eff 8-5-15; ss by #13398, eff 6-22-22 (formerly Ph 706.02) (see Revision Note at chapter heading for Ph 700)N.H. Pharmacy Board
(a) A pharmacist shall review the patient record and each prescription presented for dispensing for purposes of identifying:
- (1) Over-utilization or under-utilization;
- (2) Therapeutic duplication;
- (3) Drug-disease contraindication;
- (4) Drug-drug interactions;
- (5) Incorrect drug dosage or duration of drug treatment;
- (6) Drug-allergy interactions; and
- (7) Clinical abuse or misuse.
- (b) Upon recognizing any of the above, the pharmacist shall take appropriate steps to avoid or resolve the problem which might include consultation with the prescriber.
Source. #5552 INTERIM eff 1-8-93, EXPIRES 5-8-93; ss by #5622, eff 5-8-93; ss by #6181-B, eff 2-5-96, EXPIRED: 2-5-04 New. #8316, eff 3-26-05, EXPIRED: 3-26-13 New. #10903, eff 8-5-15; ss by #13398, eff 6-22-22 (formerly Ph 706.02) (see Revision Note at chapter heading for Ph 700)